ibuprofen has been researched along with Cancer of Kidney in 2 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, X | 2 |
| Teng, Y | 2 |
| Zhu, C | 2 |
| Li, Z | 2 |
| Liu, T | 2 |
| Sun, Y | 2 |
| Han, S | 2 |
| Palayoor, ST | 1 |
| Burgos, MA | 1 |
| Shoaibi, A | 1 |
| Tofilon, PJ | 1 |
| Coleman, CN | 1 |
2 other studies available for ibuprofen and Cancer of Kidney
| Article | Year |
|---|---|
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |
Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Carriers; Humans; Ibuprofen; Kidney Neoplasms | 2022 |
Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Basic Helix-Loop-Helix Transcription Factors; Blotting, Wes | 2004 |